Deutsch, MelanieVasileiadi, SofiaPapadopoulos, NikolaosThe coronavirus SARS-CoV-2 was identified as the cause of COVID-19, a severe acute respiratory syndrome. Several clinical studies refer to liver injury as the most frequent clinical extrapulmonary manifestation. In this review, we summarize the available clinical data concerning liver injury during COVID-19. Although the underlying mechanism of liver impairment is somewhat unclear, transaminases and bilirubin levels are elevated in a substantial proportion of patients. Moreover, more severe alterations in liver enzymes may correlate with a worse clinical course of COVID-19. However, several other cofactors, such as drug-induced liver injury, hyper-inflammatory response to infection, hypoxic hepatitis or preexisting underlying liver disease, cannot be excluded. Keywords Coronavirus, SARS-CoV-2, COVID-19, liver injury Ann Gastroenterol 2020; 33 (5): 459-464text/htmlapplication/pdfhttp://www.annalsgastro.gr/index.php/annalsgastro/article/view/5214engHellenic Society of GastroenterologyCopyright (c) 2020 Annals of Gastroenterology1792-74631108-7471Annals of Gastroenterology; Volume 33, No 5 (2020); 459COVID-19 and liver injury: where do we stand?info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion2020-08-12Δημοσίευση σε περιοδικόPublication in journalΓαστροεντερολογίαGastroenterologyisi -Gastroenterology & Hepatology covers resources on the anatomy, physiology, biochemistry, and pathology of the digestive system. This category includes specific resources on the prognosis and treatment of digestive diseases; stomach ulcers; metabolic, genetic, infectious and chemically induced diseases of the liver; colitis; diseases of the pancreas and diseases of the rectum.Επιστημονικό άρθροScientific articleΒιβλιοκρισία / ΒιβλιοπαρουσίασηBook reviewΕλληνική Γαστροεντερολογική ΕταιρίαGreek Aggregator OpenArchives.gr | National Documentation Centre (EKT)other